| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |